PET Imaging

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.

A modern collection of imaging innovations offers a new path to healthcare and medical research, framing a new era of medical diagnostic solutions
Feature | Magnetic Resonance Imaging (MRI) | By Robert L. Bard, MD, and Lennard M. Gettz, EdD
The Full Body Imaging Movement: A Strategic Upgrade of the MRI

Since the advent of the magnetic resonance imaging (MRI) exam on human patients in the late 1970s, this innovation ...

Time September 25, 2023
arrow
Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT mаchines, using the perovskite-based photoconverters
News | X-Ray
Moscow Scientists Initiate Groundbreaking Testing of X-ray Machine Detectors

September 21, 2023 — Scientists in Moscow have successfully engineered a prototype detector for X-ray and PET/CT ...

Time September 21, 2023
arrow
The clinical study of Positron’s Affinity PET-CT is designed to provide key information that evaluate the new system and its full capabilities with multiple radiopharmaceuticals and new coronary flow software applications that will enhance physician’s diagnostic analysis
News | PET-CT
Positron Corporation Announces Start of Clinical Study of Affinity PET-CT Device

September 8, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce ...

Time September 08, 2023
arrow
The AURA 10 is now poised to help enhance surgical outcomes in the United States
News | PET-CT
XEOS Receives Approval by US FDA for the AURA 10 PET-CT Specimen Imager for the Operating Room

September 7, 2023 — The groundbreaking AURA 10 specimen imager by Belgian MedTech pioneer XEOS has been cleared by the ...

Time September 07, 2023
arrow
The iba Cyclone IKON
Feature | PET Imaging
PET Radiotracer Market anticipated to reach $3.2 Billion in Revenues by 2031

According to a new report from Transparency Market Research (TMR), PET radiotracers are expected to rise at a CAGR of 8 ...

Time September 05, 2023
arrow
In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid in therapy selection without the need for a biopsy
News | Prostate Cancer
PSMA PET/CT Waives the Need for Pre-imaging Biopsy in Elderly Patients

August 15, 2023 — In elderly patients with suspected prostate cancer, PSMA PET/CT can diagnose advanced disease and aid ...

Time August 15, 2023
arrow
Now radiology departments, imaging technologists and medical experts have a solution they can use to help tackle these challenges.
Sponsored Content | Case Study | Enterprise Imaging
Redefining Radiology

The healthcare industry faces many different types of obstacles in today’s challenging marketplace. Staff shortages ...

Time August 01, 2023
arrow
FDA-approved in May 2023, POSLUMA is commercially available through 36 radiopharmacies across the United States
News | Prostate Cancer
Blue Earth Diagnostics Announces Addition of POSLUMA (Flotufolastat F 18) Injection to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer

July 28, 2023 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 28, 2023
arrow
Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design, that could help to create better images which help doctors diagnose patients’ conditions more easily and safely.
News | Magnetic Resonance Imaging (MRI)
Copper Could Help Create Clearer MRI Images and Improved Diagnosis

July 27, 2023 — Scientists have found a new use for copper in magnetic resonance imaging (MRI) contrast agent design ...

Time July 27, 2023
arrow
Researchers at Monash University have designed a new co-training AI algorithm for medical imaging that can effectively mimic the process of seeking a second opinion.
News | PET Imaging
PSMA PET Imaging Improves Accuracy of Predicting Prostate Cancer Recurrence

July 26, 2023 — A molecular imaging tool developed by researchers at the University of California’s two nationally ...

Time July 26, 2023
arrow
A collaboration to advance development of a fibroblast activation protein (FAP)-targeted PET diagnostic compound for a broad array of epithelial-derived cancers. 
News | Radiopharmaceuticals and Tracers
Ratio Therapeutics, In Collaboration with Lantheus and PharmaLogic, Announce First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

July 25, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...

Time July 25, 2023
arrow
Positron Corporation has entered an Novation Agreement with Shenyang Intelligent Neuclear Medical Technology Co, LTD (Intelligent Neuclear Medical), a wholly owned subsidiary of Neusoft Medical Systems (Neusoft.
News | PET-CT
Positron Corporation Enters New Manufacturing & Components Supplier Cooperative with Neusoft Medical Systems Subsidiary for New PET-CT Device

July 25, 2023 — Positron Corporation, a leading molecular imaging medical device company, is pleased to announce that ...

Time July 25, 2023
arrow
With uMI Panorama, United Imaging Continues to Push the Envelope on Whole-Body System Performance
News | PET-CT
United Imaging Introduces Next-Generation PET/CT Systems and Integrated Molecular Technology Platform at SNMMI

July 12, 2023 — United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment and ...

Time July 12, 2023
arrow
For teleradiology groups, ensuring they have the radiologist capacity and technology in place will be essential to capitalize on the opportunity for robust market growth
Feature | Teleradiology | By Arun Gill
Outpatient Imaging And Teleradiology Changing the Market Dynamic in the US

The healthcare market is witnessing a dynamic shift in how and where patients want to receive care, with the flexibility ...

Time July 12, 2023
arrow
A collaboration to advance development of a fibroblast activation protein (FAP)-targeted PET diagnostic compound for a broad array of epithelial-derived cancers
News | Radiopharmaceuticals and Tracers
First Patient Dosed in Phase I Study Evaluating a Novel FAP-Targeted Radiopharmaceutical for PET Imaging

July 11, 2023 — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative ...

Time July 11, 2023
arrow
City of Hope researchers establish foundation to expand SCINTIX therapy using a prostate cancer-specific PET radiotracer
News | Prostate Cancer
RefleXion Highlights Clinical Study Results for Future Prostate Cancer Treatment

July 3, 2023 — RefleXion Medical, Inc., a therapeutic oncology company, today announced that results of a prospective ...

Time July 03, 2023
arrow
Digital detectors with proprietary LSO crystals deliver high-resolution imaging
News | PET-CT
Siemens Healthineers Debuts Biograph Vision.X PET/CT Scanner

June 29, 2023 — At the 2023 Annual Meeting of the Society of Nuclear Medicine & Molecular Imaging (SNMMI), June 24-27 at ...

Time June 29, 2023
arrow
The integration of its advanced AIR technologies with the SIGNA PET/MR AIR system, to enhance diagnostic precision, simplify treatment evaluation, while elevating patient comfort
News | SNMMI
GE HealthCare Advances PET/MR Capabilities with AIR Technologies

June 28, 2023 — GE HealthCare is set to unveil SIGNA PET/MR AIR[i], at the Society of Nuclear Medicine and Molecular ...

Time June 28, 2023
arrow
Molecular imaging with 18F-flubatine PET/MRI has shown that neuroreceptors in the brains of individuals with obesity respond differently to food cues than those in normal-weight individuals, making the neuroreceptors a prime target for obesity treatments and therapy
News | SNMMI
Molecular Imaging Identifies Brain Changes in Response to Food Cues; Offers Insight into Obesity Interventions

June 28, 2023 — Molecular imaging with 18F-flubatine PET/MRI has shown that neuroreceptors in the brains of individuals ...

Time June 28, 2023
arrow
A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake, sustained tumor retention, and high contrast in preclinical models, making it a prime candidate for a novel theranostics approach
News | SNMMI
Novel Theranostic Agent Targets Multiple Cancer Types

June 28, 2023 — A newly discovered radionuclide-based agent (CB-2PA-NT) has been shown to have high tumor uptake ...

Time June 28, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now